Pfizer Limited announced the appointment of Meenakshi Nevatia as an Additional Director and the Managing Director for a period of five years with effect from 3rd April 2023. She succeeds S Sridhar, who announced his early retirement in August 2022, according to ETHRWorld report. Meenakshi is a seasoned leader with nearly 30 years of business…
Drug discovery and development company Mission Therapeutics recently said that it has raised $15mn in equity investment. The funding round was led by company’s existing investor Pfizer Ventures, the venture capital arm of Pfizer Inc. Along with the investment, Mission and Pfizer Inc. have also expanded their relationship by entering into an evaluation and option…
GlaxoSmithKline, a British multinational pharmaceutical company, announced that it has sold its stake in Unilever’s Indian business for $3.35 billion. The funds will help GSK in its goal of reinvigorating its drug development pipeline, having made costly bets on experimental cancer treatments and future cell and gene therapies amid sluggish revenue growth. The 133.77 million…
Mylan N.V.and Pfizer announced the appointment of Sanjeev Narula as CFO of Viatris. He is currently working as Chief Financial Officer of Upjohn, a division of Pfizer. Viatris is the new company that will result from the planned combination of Mylan and Upjohn. Narula has been working with Pfizer for over 16 years. At Upjohn,…
GlaxoSmithKline plc has reached an agreement with Pfizer Inc to combine their consumer health businesses into a new world-leading Joint Venture, with combined sales of approximately £9.8 billion ($12.7 billion). The JV will operate globally under the GSK Consumer Healthcare name. Under the terms of the transaction, GSK will have a majority controlling equity interest…